Results 11 to 20 of about 68,812 (293)

Human natural killer cell maturation defect supports in vivo CD56(bright) to CD56(dim) lineage development. [PDF]

open access: yesPLoS ONE, 2012
Two populations of human natural killer (NK) cells can be identified in peripheral blood. The majority are CD3(-)CD56(dim) cells while the minority exhibits a CD3(-)CD56(bright) phenotype.
Carolina Inés Domaica   +9 more
doaj   +3 more sources

Cutaneous CD4+/ CD56 hematodermic neoplasm

open access: yesIndian Journal of Dermatology, Venereology, and Leprology, 2010
CD4+/CD56+ hematodermic neoplasm, formerly known as blastic NK cell lymphoma, is a rare and aggressive neoplasm with a high incidence of cutaneous involvement, risk of leukemic dissemination and poor prognosis. The characteristic features are expression of the T helper inducer cell marker CD4 and the NK-cell marker CD56 in the absence of other T cell ...
Zindanci, Ilkin   +4 more
openaire   +3 more sources

CD56 Expression in Odontogenic Cysts and Tumors

open access: yesJournal of dental research, dental clinics, dental prospects, 2014
Journal of Dental Research, Dental Clinics, Dental Prospects; eISSN 2008 ...
Zohreh Jaafari-Ashkavandi   +2 more
openaire   +4 more sources

CD56 regulates human NK cell cytotoxicity through Pyk2 [PDF]

open access: yeseLife, 2020
Human natural killer (NK) cells are defined as CD56+CD3−. Despite its ubiquitous expression on human NK cells the role of CD56 (NCAM) in human NK cell cytotoxic function has not been defined.
Justin T Gunesch   +8 more
doaj   +2 more sources

Giant omental lipoblastoma and CD56 expression

open access: yesAfrican Journal of Paediatric Surgery, 2013
We report a case of giant omental lipoblastoma in a 13-month-old boy, which was treated successfully by total excision. Tumor cells were positive for S100, CD34 and CD56. This is the fi rst report of lipoblastoma expressing CD56, a fact that could be used to differentiate lipoblastoma from liposarcoma.
Go Miyano   +6 more
core   +6 more sources

Stress and Recurrent Miscarriage [PDF]

open access: yes, 2010
This thesis investigated the role of stress in RM using both psychometric and biochemical measures. The majority of previous studies on the impact of stress on RM only addressed the psychological aspect without concurrent biochemical stress measurements.
Li, Wei
core   +7 more sources

Prognostic Value of CD56 Expression in Multiple Myeloma [PDF]

open access: yesResearch in Oncology, 2020
Background: Understanding the prognostic markers of multiple myeloma (MM) helps in optimizing therapeutic approaches. CD56 is frequently expressed by malignant plasma cells and its use as a prognostic marker in MM is promising.
Salah Khallaf   +7 more
doaj   +1 more source

The Assessment of CD56 and CD117 Expressions at the Time of the Diagnosis in Multiple Myeloma Patients

open access: yesTurkish Journal of Hematology, 2017
Objective: The purpose of this study is to investigate the relationship between the CD56 and CD117 expressions and the clinical and laboratory findings in multiple myeloma (MM) patients.
Funda Ceran   +3 more
doaj   +1 more source

Adverse outcome of AML with aberrant CD16 and CD56 NK cell marker expression. [PDF]

open access: yes, 2018
Natural killer cells mediate antibody-dependent cell-mediated cytotoxicity, and CD16 exerts key functions to induce antibody-dependent cell-mediated cytotoxicity response.
Pabst Müller, Thomas Niklaus   +11 more
core   +1 more source

Expression of Adhesion Molecule CD56 in Tumor Plasma Cells in Bone Marrow as a Prognostic Factor in Multiple Myeloma

open access: yesКлиническая онкогематология, 2019
Aim. To study immunohistochemical parameters of tumor plasma cells in bone marrow and to assess how the expression of adhesion molecule CD56 impacts overall survival (OS) of multiple myeloma (MM) patients. Materials & Methods.
Maiya Valer’evna Firsova   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy